EFFECT OF LONG-TERM ENOXAPARIN THERAPY ON RISK OF RECURRENT VENOUS THROMBOEMBOLIC COMPLICATIONS AND RECANALIZATION OFTHROMBOSED VEINS
The article presents the results of its own study of the effect of long-term (not less than 30 days) enoxa-parin therapy (1 mg/kg administered subcutaneously every 12h) on the risk of recurrent venous thromboembolic complications (VTC) and recanalization of thrombosed deep veins. The enoxaparin ther...
Saved in:
Main Authors: | N. M. Vorobyova (Author), O. V. Ermolina (Author), T. V. Balakhonova (Author), A. I. Kiriyenko (Author), E. P. Panchenko (Author) |
---|---|
Format: | Book |
Published: |
«REMEDIUM GROUP» Ltd.,
2015-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism
by: Aliya Abdulla, et al.
Published: (2023) -
DABIGATRAN ETEXILATE FOR THE TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS
by: N. M. Vorobieva, et al.
Published: (2015) -
Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence
by: Filippo Drago, et al.
Published: (2020) -
The use of enoxaparin as venous thromboembolism prophylaxis in bariatric surgery: A retrospective cohort study
by: Esraa Altawil, et al.
Published: (2022) -
Apixaban role in the treatment of venous thromboembolic complications in patients with active cancer
by: E. P. Panchenko
Published: (2020)